Bibliografia UJ CM

1/2
Hermann Haller, Sadayoshi Ito, Joseph L. Izzo, Andrzej Januszewicz, Shigehiro Katayama, Jan Menne, Albert Mimran, Ton J. Rabelink, Eberhard Ritz, Luis M. Ruilope, Lars C. Rump, Giancarlo Viberti, ROADMAP Trial Investigators.
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.
New England Journal of Medicine
2011 : Vol. 364, nr 10, s. 907-917, il., bibliogr. 26 poz., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 53.298
2/2
Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke, Tomas Berl, Marc A. Pohl, Julia B. Lewis, Eberhard Ritz, Robert C. Atkins, Richard Rohde, Itmar Raz, The Colaborative Study Group.
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
New England Journal of Medicine
2001 : Vol. 345, nr 12, s. 851-860, il., bibliogr. 26 poz.
LR
ORG
AIF
IF: 29.065
Adres url:
Wyświetl ponownie stosując format: